Ignite Creation Date:
2024-05-06 @ 8:24 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06360510
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-04-11
First Post:
2024-04-07
Brief Title:
Comparison of 5 Dextrose and Betamethasone Injections in Patients With Carpal Tunnel Syndrome
Sponsor:
Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
Organization:
Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
Study Overview
Official Title:
Comparison of the Effectiveness of Ultrasound-guided 5 Dextrose and Betamethasone Injections in Patients With Carpal Tunnel Syndrome
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of the study is to compare the effectiveness of ultrasound-guided betamethasone and 5 dextrose injection which is routinely applied in clinical practice in patients with mild and moderate carpal tunnel syndrome CTS
Detailed Description:
It is planned as an observational single-center clinical studyA total of 28 patients diagnosed with mild-moderate carpal tunnel syndrome who meet the inclusion criteria will be included in the studyPatients who had been experiencing trigger finger symptoms for at least three month and who presented to the Gaziler Physical Medicine and Rehabilitation Training and Research Hospital affiliated with the Health Sciences University Faculty of Medicine
Patients will be divided into two groups One group will receive 5 dextrose the other group will receive 1 session of local injection by mixing Celeston chronodose 1ml3 mg betamethasone acetate3947 mg betamethasone disodium phosphate equivalent to 3 mg betamethasone and 1 ml 2 prilocaine
Evaluations will be made before injection at weeks 4 and 12
Patients will be divided into two groups One group will receive 5 dextrose the other group will receive 1 session of local injection by mixing Celeston chronodose 1ml3 mg betamethasone acetate3947 mg betamethasone disodium phosphate equivalent to 3 mg betamethasone and 1 ml 2 prilocaine
Evaluations will be made before injection at weeks 4 and 12
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None